Concepedia

Anthony Manibusan

AM

Statistics

Publications

12

Citations

1.1K

H-Index

12

Active since

1999

Affiliations

Ambrx (United States)(Current)

Torrey Pines Institute For Molecular Studies

Merck & Co., Inc., Rahway, NJ, USA (United States)

Scripps Research Institute

United States Military Academy

Anthony Manibusan is an author at Ambrx (United States) specializing in pharmacy, antibody conjugation, and antibody conjugates.

Publications per year

1999–2018

12

Publications

12

A general approach to site-specific antibody drug conjugates

Feng Tian, Yingchun Lu, Anthony Manibusan et al. · Proceedings of the National Academy of Sciences · 2014 · 317 citations · Full text

, , +17

FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents

James Mu, Jason Pinkstaff, Zhihua Li et al. · Diabetes · 2011 · 159 citations · Full text

, , +13

Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody–Drug Conjugates

Jeffrey C. Kern, Mark T. Cancilla, Deborah Dooney et al. · Journal of the American Chemical Society · 2016 · 141 citations

, , +17

In Vitro and In Vivo Evaluation of Cysteine and Site Specific Conjugated Herceptin Antibody-Drug Conjugates

Dowdy Jackson, John Atkinson, Claudia Guevara et al. · PLoS ONE · 2014 · 119 citations · Full text

, , +17

Novel Phosphate Modified Cathepsin B Linkers: Improving Aqueous Solubility and Enhancing Payload Scope of ADCs

Jeffrey C. Kern, Deborah Dooney, Rena Zhang et al. · Bioconjugate Chemistry · 2016 · 94 citations

, , +17

1–5 of 12